EXAMPLES OF OUR WORK

Hover over images below to see what we have recently done or currently doing.

If you would like to learn more, please contact us.

Product Concept Testing
Validated 3 new product concepts through qualitative + quantitative studies.

Product Concept Testing

Insight Research
Qualitative Testing with small animal GPs and KOLs for 3 new small animal speciality therapeutics.

Insight Research

New Product Valuations
New product forecasts for 3 speciality therapeutics using our proprietary Propelligence model that includes scenario planning & market research.

New Product Valuations

Go to Market Strategy
Developed launch strategies for 2 veterinary therapeutics & 1 human therapeutic as well as pitch decks for potential investors & partners.

Go to Market Strategy

R&D Project Management

Lead clinical development projects with multiple vendors for 2 speciality therapeutics and 1 parasiticide. 

R&D Project Management

Commercial Partnering
Developed the strategy and is leading negotiations with  commercial partners for animal and human health products.

Commercial Partnering

Third Party Manufacturing
Provided guidance on formulations and conducted COGS analyses on 2 veterinary therapeutics.

Third Party Manufacturing

Key Opinion Leaders

Conducted KOL outreach and built Advisory Boards in the areas of oncology and internal medicine. 

Key Opinion Leaders

Public Relations
Developed and executed trade releases for new product launch and patient recruitment for clincal trials.

Public Relations

Clinical Development Project Planning
Developed detailed clinical development project plans for 3 specialty therapeutics and 1 parasiticide.

Clinical Development Project Planning

Quality Assurance Audits

We have conducted QA site audits for two laboratory studies and for an EPA manufacturing site that wanted to transition to an FDA approved site.

Quality Assurance Audits

Regulatory Strategy
Built plans to gain approval in US and EU for veterinary therapeutics, medical devices and human therapeutics.

Regulatory Strategy

Tradename Development

Created an FDA acceptable tradename for an upcoming veterinary specialty therapeutic drug.

Tradename Development

SCULLION STRATEGY GROUP clear - no LLC.p
iStock-807201522.jpg
Due Diligence

Conducted a deep dive scientific and commercial review for a human oncology platform to prepare for commercial partner.

Due Diligence